Article info
PostScript
Letter
Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum
- Correspondence to Dr Maria O'Sullivan, Clinical Medicine, Trinity Centre for Health Science, Adelaide and Meath incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland; maria.osullivan{at}tcd.ie
Citation
Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum
Publication history
- First published October 4, 2010.
Online issue publication
February 04, 2011
Article Versions
- Previous version (4 October 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.